Literature DB >> 18753993

Leptin in nonalcoholic fatty liver disease.

Billur Canbakan1, Veysel Tahan, Huriye Balci, Ibrahim Hatemi, Burak Erer, Gulsen Ozbay, Necdet Sut, Munire Hacibekiroglu, Nese Imeryuz, Hakan Senturk.   

Abstract

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is a prevalent condition associated with obesity and insulin resistance (IR). Leptin plays a key role in the control of energy balance, and insulin sensitivity. In this study, we aimed to examine whether serum leptin levels correlate with insulin resistance, oxidative stress parameters and the severity of histological changes in NAFLD.
METHODS: Fifty-two patients (M/F: 28/24) with no alcohol intake and biopsy-proven diagnosis of NAFLD were studied. Serum leptin levels were measured by radioimmunoassay. HOMA (homeostasis model assessment) IR index was calculated. Comparisons between the patients with NAFLD and non-alcoholic steatohepatitis (NASH) were performed using the Student's t test. Multivariate regression analysis and the area under the receiver operating characteristic (ROC) curve were used to identify the independent predictors for NASH.
RESULTS: We found no association between serum leptin, fasting insulin levels, and oxidative stress parameters. ROC curve and multiple regression analysis revealed no association between the severity of histological changes and serum leptin levels. During six months followed-up period only NASH group with elevated leptin levels had significant reductions of ALT and AST values (p = 0.03, and 0.005, respectively).
CONCLUSION: Our findings show a preventive effect of leptin against progressive liver injury in NAFLD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18753993

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  10 in total

Review 1.  Role of adipokines and peroxisome proliferator-activated receptors in nonalcoholic fatty liver disease.

Authors:  Vettickattuparambil George Giby; Thekkuttuparambil Ananthanarayanan Ajith
Journal:  World J Hepatol       Date:  2014-08-27

Review 2.  From fatty liver to fibrosis: a tale of "second hit".

Authors:  Metin Basaranoglu; Gökcen Basaranoglu; Hakan Sentürk
Journal:  World J Gastroenterol       Date:  2013-02-28       Impact factor: 5.742

3.  Adipocyte (Pro)Renin-Receptor Deficiency Induces Lipodystrophy, Liver Steatosis and Increases Blood Pressure in Male Mice.

Authors:  Chia-Hua Wu; Shayan Mohammadmoradi; Joel Thompson; Wen Su; Ming Gong; Genevieve Nguyen; Frédérique Yiannikouris
Journal:  Hypertension       Date:  2016-05-16       Impact factor: 10.190

Review 4.  Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis.

Authors:  Stergios A Polyzos; Konstantinos N Aronis; Jannis Kountouras; Dimitrios D Raptis; Maria F Vasiloglou; Christos S Mantzoros
Journal:  Diabetologia       Date:  2015-09-26       Impact factor: 10.122

5.  Perforin Acts as an Immune Regulator to Prevent the Progression of NAFLD.

Authors:  Qian Wang; Dehai Li; Jing Zhu; Mingyue Zhang; Hua Zhang; Guangchao Cao; Leqing Zhu; Qiping Shi; Jianlei Hao; Qiong Wen; Zonghua Liu; Hengwen Yang; Zhinan Yin
Journal:  Front Immunol       Date:  2020-05-22       Impact factor: 7.561

6.  Thiazolidinedione induces a therapeutic effect on hepatosteatosis by regulating stearoyl-CoA desaturase-1, lipase activity, leptin and resistin.

Authors:  Hessah Mohammed Al-Muzafar; Kamal Adel Amin
Journal:  Exp Ther Med       Date:  2018-08-02       Impact factor: 2.447

7.  Effect of Carnitine and herbal mixture extract on obesity induced by high fat diet in rats.

Authors:  Kamal A Amin; Mohamed A Nagy
Journal:  Diabetol Metab Syndr       Date:  2009-10-16       Impact factor: 3.320

8.  Leptin increases mitotic index and regeneration ratio in hepatectomized rats.

Authors:  Murat Cilekar; Onur Uysal; Cengiz Bal; Serkan Turel; Sezgin Yılmaz
Journal:  Med Sci Monit Basic Res       Date:  2013-11-13

Review 9.  Nonalcoholic fatty liver disease: Diagnostic biomarkers.

Authors:  Fatemeh Hadizadeh; Elham Faghihimani; Peyman Adibi
Journal:  World J Gastrointest Pathophysiol       Date:  2017-05-15

10.  Hepatoprotective and Renoprotective Properties of Lovastatin-Loaded Ginger and Garlic Oil Nanoemulsomes: Insights into Serum Biological Parameters.

Authors:  Syed Ali Faran; Sajid Asghar; Syed Haroon Khalid; Ikram Ullah Khan; Muhammad Asif; Ikrima Khalid; Umar Farooq Gohar; Tanveer Hussain
Journal:  Medicina (Kaunas)       Date:  2019-09-09       Impact factor: 2.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.